Analysis of Urine Podocalyxin in Type 2 Diabetes Mellitus Subjects With and Without Diabetic Nephropathy
Article Sidebar
Main Article Content
Abstract
Type 2 diabetes mellitus is the most common cause of diabetes, consist from about 85% of cases. Diabetic nephropathy is a complication of diabetes mellitus in the kidneys which can end up as kidney failure. Podocalyxin (PDX) is a protein expressed in kidney podocytes that is involved in various cancers, and is also essential for kidney development. The research design was carried out using observational and cross-sectional analytic methods with total participants of 25 DM with diabetic nephropathy and 25 DM without diabetic nephropathy with a purposive probability sampling technique. This research conducted at the Endocrine Polyclinic, Clinical Pathology Laboratory, Hasanuddin University Medical Research Center (HUM-RC) Laboratory, Hasanuddin University Hospital, Makassar. The results showed that the urinary PDX level in DM subjects with nephropathy were 1.160 ng/mL and DM without nephropathy were 0.167 ng/mL (p<0.001), the urine albumin/creatinine ratio (ACR) of DM subjects with nephropathy were 644.74 mg/ g and DM without nephropathy of 10.071 mg/g (p<0.001) and the correlation test results of urine PDX and urine ACR in DM subjects with nephropathy (r=0.510; p=0.001). This study concluded that there was a significant difference between urinary PDX in DM with and without diabetic nephropathy, there was a significant difference between urine ACR levels in DM with and without diabetic nephropathy, and there was a relationship between urinary PDX levels and urine ACR in DM subjects with diabetic nephropathy.
Downloads
Article Details
Copyright (c) 2023 Jusni Ekasari Pelu, Liong Boy Kurniawan, Yuyun Widaningsih, Alfian Zainuddin, Husaini Umar, Nurahmi Nurahmi, Theosobia Grace Orno
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Durruty P, & Sanzana, Sanhueza M, Sanhueza L. Pathogenesis of Type 2 Diabetes
Mellitus. IntechOpen. 2019. DOI: 10.5772/intechopen.83692 DOI: https://doi.org/10.5772/intechopen.83692
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care. 2022; 45(11): 2753–2786. DOI: 10.2337/dci22-0034 DOI: https://doi.org/10.2337/dci22-0034
Buzzetti R, Maddaloni E, Gaglia J, Leslie RD, Wong FS, Boehm BO. Adult-onset autoimmune diabetes. Nature reviews. Disease primers. 2022; 8(1): 63. DOI: 10.1038/s41572-022-00390-6 DOI: https://doi.org/10.1038/s41572-022-00390-6
Ossolinski G, Jiwa M, McManus A, Parsons R. Do images of a personalised future body shape help with weight loss? A randomised controlled study. Trials. 20117; 18(1): 180. DOI: 10.1186/s13063-017-1907-6 DOI: https://doi.org/10.1186/s13063-017-1907-6
Ivanoshchuk DE, Shakhtshneider V, Rymar OD, Ovsyannikova AK, Mikhailova SV, Fishman VS, Valeev ES, Orlov PS, Voevoda MI. (2021). The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes among Western Siberia Patients. Journal of personalized medicine. 2021: 11(1): 57. DOI: 10.3390/jpm11010057 DOI: https://doi.org/10.3390/jpm11010057
Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed research international. 2021: 1497449. DOI: 10.1155/2021/1497449 DOI: https://doi.org/10.1155/2021/1497449
Jana S, Mitra P, Roy S. Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review. Diseases. 2022; 11. DOI: 10.3390/diseases11010008 DOI: https://doi.org/10.3390/diseases11010008
Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ (Clinical research ed.). 2017; 356, i6505. DOI: 10.1136/bmj.i6505 DOI: https://doi.org/10.1136/bmj.i6505
Moh MC, Pek SLT, Sze KCP, Low S, Subramaniam T, Ang K, Tang WE, Lee SBM, Sum CF, Lim SC. Associations of non-invasive indices of liver steatosis and fibrosis with progressive kidney impairment in adults with type 2 diabetes. Acta diabetologica. 2023. DOI: 10.1007/s00592-023-02058-3 DOI: https://doi.org/10.1007/s00592-023-02058-3
Sun D, Zhao X, Meng L. Relationship between urinary podocytes and kidney diseases. Renal failure. 2012; 34(3): 403–407. DOI: 10.3109/0886022X.2011.649627 DOI: https://doi.org/10.3109/0886022X.2011.649627
Mizdrak M, Kumrić M, Kurir TT, Božić, J. Emerging Biomarkers for Early Detection of Chronic Kidney Disease. Journal of personalized medicine. 2022 12(4), 548. DOI: 10.3390/jpm12040548 DOI: https://doi.org/10.3390/jpm12040548
Wu F, Chen Y, Xiao H, Zou Z, Ning J, Chen H, Zou H. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2018; 38(9): 1126–1130. DOI: 10.12122/j.issn.1673-4254.2018.09.17
Kostovska I, Trajkovska KT, Cekovska S, Topuzovska S, Kavrakova JB, Spasovski G, Kostovski O, Labudovic D. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy. Romanian journal of internal medicine = Revue roumaine de medecine interne. 2020; 58(4): 233–241. DOI: 10.2478/rjim-2020-0023 DOI: https://doi.org/10.2478/rjim-2020-0023
Hara M, Yamagata K, Tomino Y, Saito A, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Yan K. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia. 2012; 55(11): 2913–2919. DOI: 10.1007/s00125-012-2661-7 DOI: https://doi.org/10.1007/s00125-012-2661-7
Wang R, Yao C, Liu F. Association between Renal Podocalyxin Expression and Renal Dysfunction in Patients with Diabetic Nephropathy: A Single-Center, Retrospective Case-Control Study. BioMed research international. 2020. 7350781. DOI: 10.1155/2020/7350781 DOI: https://doi.org/10.1155/2020/7350781
Trimarchi H, Coppo R. Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019; 34(8): 1280–1285. DOI: 10.1093/ndt/gfy413 DOI: https://doi.org/10.1093/ndt/gfy413
Leung JC, Lai KN, Tang SC. Role of Mesangial-Podocytic-Tubular Cross-Talk in IgA Nephropathy. Seminars in nephrology. 2018; 38(5): 485-495. DOI: 10.1016/j.semnephrol.2018.05.018 DOI: https://doi.org/10.1016/j.semnephrol.2018.05.018
Shoji M, Kobayashi K, Takemoto M, Sato Y, Yokote K. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2016; 21(2): 164–167. DOI: 10.3109/1354750X.2015.1118551 DOI: https://doi.org/10.3109/1354750X.2015.1118551
Inoue K. Urinary Podocyte Biomarkers and Glomerular Histologic Change. Kidney360. 2022;3(3): 407–409. DOI: 10.34067/KID.0008212021 DOI: https://doi.org/10.34067/KID.0008212021
Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. Clinical journal of the American Society of Nephrology : CJASN. 2012; 7(9); 1385-93. DOI: 10.2215/CJN.08110811 DOI: https://doi.org/10.2215/CJN.08110811
Abe H, Sakurai A, Ono H, Hayashi S, Yoshimoto S, Ochi A, Ueda S, Nishimura K, Shibata E, Tamaki M, Kishi F, Kishi S, Murakami T, Nagai K, Doi T. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy. The journal of medical investigation : JMI. 2018; 65(3.4): 208–215. DOI: 10.2152/jmi.65.208 DOI: https://doi.org/10.2152/jmi.65.208
Akankwasa G, Jianhua L, Guixue C, Changjuan A, Xiaosong Q. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases. Biomarkers in medicine. 2018; 12(8): 927–935. DOI: 10.2217/bmm-2018-0152 DOI: https://doi.org/10.2217/bmm-2018-0152
Watanabe K, Okamoto T, Saitou T, Iwasaki A, Matsushita H, Takeuchi K, Asai A, Ito Y, Hara M, Wakatsuki A. Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia. Pregnancy hypertension. 2023; 32: 1–6. DOI: 10.1016/j.preghy.2023.02.001 DOI: https://doi.org/10.1016/j.preghy.2023.02.001
Ikuma D, Hiromura K, Kajiyama H, Suwa J, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Kurosawa H, Hirayama Y, Yokota K, Araki Y, Sato K, Asanuma YF, Akiyama Y, Hara M, Nojima Y, Mimura T. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis. Lupus. 2018; 27(3): 484–493. DOI: 10.1177/0961203317734918 DOI: https://doi.org/10.1177/0961203317734918
Kimura M, Toyoda M, Saito N, et al. A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy. Journal of Diabetes Research. 2019 ;2019:9475637. DOI: 10.1155/2019/9475637 DOI: https://doi.org/10.1155/2019/9475637
